Black Diamond Therapeutics (BDTX) Cash & Equivalents (2018 - 2026)
Black Diamond Therapeutics (BDTX) reported Cash & Equivalents of $19.19 million for Q2 2026, down 36.0% from $29.99 million a year earlier and down 36.2% from the prior quarter.
Black Diamond Therapeutics (BDTX) Cash & Equivalents (2018 - 2026) Analysis & Trends
At the end of FY2025, Black Diamond Therapeutics posted Cash & Equivalents of $20.99 million, down 42.4% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -9.5% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $36.44 million in FY2024 (-35.2%), $56.22 million in FY2023 (+63.8%), $34.32 million in FY2022 (-47.8%) and $65.8 million in FY2021 (+90.1%).
- The Q2 2026 figure ranks as the lowest quarterly Cash & Equivalents since Q1 2021.
- Year over year, Cash & Equivalents has now declined in each of the last three quarters, with growth averaging 8.5% over the last eight quarters.
- The high point for year-over-year Cash & Equivalents in five years was Q1 2025 (growth of 287.2%); the low point was Q1 2026 (a decline of 69.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $30.07 million (Q1 2026), $20.99 million (Q4 2025) and $30.86 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Black Diamond Therapeutics | 119.32 Mn | -373.60 Mn | - | 19.19 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.19 Mn |
| Mar 31, 2026 | 30.07 Mn |
| Dec 31, 2025 | 20.99 Mn |
| Sep 30, 2025 | 30.86 Mn |
| Jun 30, 2025 | 29.99 Mn |
| Mar 31, 2025 | 98.42 Mn |
| Dec 31, 2024 | 36.44 Mn |
| Sep 30, 2024 | 23.43 Mn |
| Jun 30, 2024 | 32.81 Mn |
| Mar 31, 2024 | 25.42 Mn |
| Dec 31, 2023 | 56.22 Mn |
| Sep 30, 2023 | 57.98 Mn |
| Jun 30, 2023 | 41.89 Mn |
| Mar 31, 2023 | 39.14 Mn |
| Dec 31, 2022 | 34.32 Mn |
| Sep 30, 2022 | 53.96 Mn |
| Jun 30, 2022 | 55.88 Mn |
| Mar 31, 2022 | 54.08 Mn |
| Dec 31, 2021 | 65.80 Mn |
| Sep 30, 2021 | 46.60 Mn |
Black Diamond Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BDTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "BDTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BDTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();